LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Linsitinib | 0.37 | uM | LJP5 | 3 | O22 | 72 | hr | 765 | 2997 | 3152 | 0.9507 | 0.9511 |
Hs 578T | Linsitinib | 1.11 | uM | LJP5 | 1 | O21 | 72 | hr | 765 | 3195 | 3140 | 1.0174 | 1.0170 |
Hs 578T | Linsitinib | 1.11 | uM | LJP5 | 2 | O21 | 72 | hr | 765 | 3148 | 3151 | 0.9988 | 0.9989 |
Hs 578T | Linsitinib | 1.11 | uM | LJP5 | 3 | O21 | 72 | hr | 765 | 3326 | 3152 | 1.0551 | 1.0532 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 1 | O20 | 72 | hr | 765 | 3102 | 3140 | 0.9878 | 0.9880 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 2 | O20 | 72 | hr | 765 | 3079 | 3151 | 0.9770 | 0.9773 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 3 | O20 | 72 | hr | 765 | 3112 | 3152 | 0.9872 | 0.9874 |
Hs 578T | Linsitinib | 10 | uM | LJP5 | 1 | O19 | 72 | hr | 765 | 2518 | 3140 | 0.8018 | 0.7945 |
Hs 578T | Linsitinib | 10 | uM | LJP5 | 2 | O19 | 72 | hr | 765 | 2607 | 3151 | 0.8272 | 0.8226 |
Hs 578T | Linsitinib | 10 | uM | LJP5 | 3 | O19 | 72 | hr | 765 | 2418 | 3152 | 0.7670 | 0.7565 |
Hs 578T | Ruxolitinib | 0.04 | uM | LJP5 | 1 | O18 | 72 | hr | 765 | 3129 | 3140 | 0.9964 | 0.9965 |
Hs 578T | Ruxolitinib | 0.04 | uM | LJP5 | 2 | O18 | 72 | hr | 765 | 3120 | 3151 | 0.9900 | 0.9901 |
Hs 578T | Ruxolitinib | 0.04 | uM | LJP5 | 3 | O18 | 72 | hr | 765 | 3150 | 3152 | 0.9992 | 0.9993 |
Hs 578T | Ruxolitinib | 0.12 | uM | LJP5 | 1 | O17 | 72 | hr | 765 | 3253 | 3140 | 1.0359 | 1.0349 |
Hs 578T | Ruxolitinib | 0.12 | uM | LJP5 | 2 | O17 | 72 | hr | 765 | 3116 | 3151 | 0.9887 | 0.9889 |
Hs 578T | Ruxolitinib | 0.12 | uM | LJP5 | 3 | O17 | 72 | hr | 765 | 3213 | 3152 | 1.0192 | 1.0187 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 1 | O16 | 72 | hr | 765 | 3129 | 3140 | 0.9964 | 0.9965 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 2 | O16 | 72 | hr | 765 | 3086 | 3151 | 0.9792 | 0.9795 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 3 | O16 | 72 | hr | 765 | 3178 | 3152 | 1.0081 | 1.0079 |
Hs 578T | Ruxolitinib | 1.11 | uM | LJP5 | 1 | O15 | 72 | hr | 765 | 2995 | 3140 | 0.9537 | 0.9540 |
Hs 578T | Ruxolitinib | 1.11 | uM | LJP5 | 2 | O15 | 72 | hr | 765 | 3041 | 3151 | 0.9649 | 0.9653 |
Hs 578T | Ruxolitinib | 1.11 | uM | LJP5 | 3 | O15 | 72 | hr | 765 | 2975 | 3152 | 0.9437 | 0.9441 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 1 | O14 | 72 | hr | 765 | 2881 | 3140 | 0.9174 | 0.9171 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 2 | O14 | 72 | hr | 765 | 2689 | 3151 | 0.8532 | 0.8504 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 3 | O14 | 72 | hr | 765 | 2765 | 3152 | 0.8771 | 0.8757 |